Clinical Trial Update: Evaluation of Gadolinium Based Contrast Agents for Portable MR Imaging Systems [NA]

View source ↗

Summary

This clinical trial update indicates enrollment by invitation to evaluate gadolinium-based contrast agents for Hyperfine's portable MRI system. The study target…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Neoplasms
• Intracranial Infections
• Intracranial Inflammatory Diseases

Drugs mentioned

• Gadolinium-based contrast agent (gadolinium-based contrast agent)

Snippet

Sponsor: Hyperfine | Conditions: Intra-axial Tumors, Extra-axial Tumors | NA | Status: ENROLLING_BY_INVITATION